Upgrade to SI Premium - Free Trial

Sapiens Reports Third Quarter 2019 Financial Results

November 4, 2019 5:15 AM

HOLON, Israel, Nov. 4, 2019 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ: SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, and a member of the Formula Group (NASDAQ: FORTY) (TASE: FORT), today announced its financial results for the third quarter ended September 30, 2019.

Sapiens Logo

Summary Results for Third Quarter 2019 (USD in millions, except per share data)

GAAP

% Change

Non-GAAP

% Change

Q3-2019

Q3-2018

Q3-2019

Q3-2018

Revenue

$82.6

$73.2

12.8%

$82.6

$73.2

12.8%

Gross Profit

$33.3

$27.8

19.9%

$36.7

$30.9

18.8%

Gross Margin

40.3%

38.0%

230 bps

44.4%

42.2%

220 bps

Operating Income

$10.1

$6.8

48.4%

$13.5

$10.3

31.7%

Operating Margin

12.2%

9.3%

290 bps

16.4%

14.0%

240 bps

Net income (*)

$7.4

$5.2

43.1%

$10.4

$7.5

37.9%

Diluted EPS

$0.15

$0.10

50%

$0.21

$0.15

40%

(*) Attributable to Sapiens' shareholders

"The third quarter demonstrated continued execution of Sapiens' 2019 priorities: top-line growth and margin expansion. Non-GAAP revenue increased 12.8%, primarily due to continued expansion in our property & casualty (P&C) divisions, and initial growth in our life & annuity (L&A) division," said Roni Al-Dor, president and CEO, Sapiens.

"A global focus on Sapiens' key objectives to leverage our offshore capabilities, along with improved economies of scale, drove a non-GAAP operating margin improvement of 240 basis points. The increase in operating income has fueled continued expansion of Sapiens' product, sales and delivery teams, all of which are key to building next year's pipeline and supporting our capacity to deliver current projects. Sapiens is confident we have built a platform that can support long term top-line growth, with the infrastructure to cost-effectively support our long-term profitability."

Continued Al-Dor: "I'm encouraged by our pipeline of business and anticipated growth for the remainder of 2019. Following the acquisition of Calculo, we are increasing our full-year, non-GAAP revenue to a range of $323 - $325 million, from a previous guidance of revenues on the higher end of $318-$323 million. The increase in revenue and the leverage from improved economies of scale allow Sapiens to increase the guidance for full-year, non-GAAP operating margin in the range of 15.8%-16.0%, compared to our previous guidance of 15.6%-15.8%."

Quarterly Results Conference Call

Management will host a conference call and webcast on November 4, 2019 at 9:30 a.m. Eastern Time (4:30 p.m. in Israel) to review and discuss Sapiens' results. Please call the following numbers (at least 10 minutes before the scheduled time) to participate: North America (toll-free): + 1-888-407-2553; International: +972-3- 9180644; UK: 0-800-917-9141

The live webcast of the call can be viewed on Sapiens' website at: https://www.sapiens.com/investor-relations/ir-events-presentations/

If you are unable to join live, a replay of the call will be accessible until November 14, 2019, as follows: North America: 1-888-295-2634; International: +972-3-925-5901

A recorded version of the webcast will also be available via the Sapiens website, for three months at the same location.

Non-GAAP Financial Measures

This press release contains the following non-GAAP financial measures: non-GAAP revenue, non-GAAP gross profit, non-GAAP operating income, non-GAAP net income attributed to Sapiens shareholders, non-GAAP basic and diluted earnings per share, Adjusted EBITDA and Adjusted Free Cash-Flow.

Sapiens believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Sapiens' financial condition and results of operations. The Company's management uses these non-GAAP measures to compare the Company's performance to that of prior periods for trend analyses, for purposes of determining executive and senior management incentive compensation and for budgeting and planning purposes. These measures are used in financial reports prepared for management and in quarterly financial reports presented to the Company's board of directors. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends, and in comparing the Company's financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.

Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: Valuation adjustment on acquired deferred revenue, amortization of capitalized software development and other intangible assets, capitalization of software development, stock-based compensation, restructuring and cost reduction costs, tax adjustments related to non-GAAP adjustments, and acquisition-related costs, which pertain to charges on behalf of M&A agreements related to future performance targets and retention criteria as determined upon acquisition date of the respective acquired company, as well as third-party services, such as, tax, accounting and legal rendered until the acquisition date.

Management of the Company does not consider these non-GAAP measures in isolation, or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company's financial statements. In addition, they are subject to inherent limitations, as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures.

To compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. Sapiens urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company's business.

Reconciliation tables of the most comparable GAAP financial measures to the non-GAAP financial measures used in this press release are included with the financial tables of this release.

The Company defines Adjusted EBITDA as net profit, adjusted for valuation adjustment on acquired deferred revenue, stock-based compensation expense, depreciation and amortization, capitalized of software development costs, compensation expenses related to acquisition and acquisition-related costs, restructuring and cost reduction costs, financial expense (income), provision for income taxes and other income (expenses). These amounts are often excluded by other companies to help investors understand the operational performance of their business.

The Company uses Adjusted EBITDA as a measurement of its operating performance, and reconciles Non-GAAP Operating Income to Adjusted EBITDA, adjusted for amortization and capitalization of capitalized software and amortization other intangible assets, stock-based compensation and acquisition-related costs, and valuation adjustment on acquired deferred revenues. The Company uses Adjusted EBITDA, because it assists in comparing the operating performance on a consistent basis by removing the impact of certain non-cash and non-operating items. Adjusted EBITDA reflects an additional way of viewing aspects of the operations that the Company believes, when viewed with the GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provide a more complete understanding of factors and trends affecting its business.

The Company uses Adjusted Free Cash-Flow as a measurement of its operating performance, and reconciles cash-flow from operating activities to Adjusted Free Cash-Flow while reducing the amounts for capitalization of software development costs and capital expenditures, and adds back payments related to investment in new campus in India, cash payments made for former acquisitions in respect of future performance targets and retention criteria as determined upon acquisition date of the respective acquired company, and were included in the cash-flow from operating activities. We believe that Adjusted Free Cash-Flow is useful in evaluating our business, because Adjusted Free Cash-Flow reflects the cash surplus available to fund the expansion of our business.

About Sapiens

Sapiens International Corporation empowers insurers to succeed in an evolving industry. The company offers digital software platforms, solutions and services for the property and casualty, life, pension and annuity, reinsurance, financial and compliance, workers' compensation and financial markets. With more than 35 years of experience delivering to over 450 organizations globally, Sapiens has a proven ability to satisfy customers' core, data and digital requirements. For more information: www.sapiens.com

Forward Looking Statement

Some of the statements in this press release may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities and Exchange Act of 1934 and the United States Private Securities Litigation Reform Act of 1995. Words such as "will," "expects," "believes" and similar expressions are used to identify these forward-looking statements (although not all forward-looking statements include such words). These forward-looking statements, which may include, without limitation, projections regarding our future performance and financial condition, are made on the basis of management's current views and assumptions with respect to future events. Any forward-looking statement is not a guarantee of future performance and actual results could differ materially from those contained in the forward-looking statement.

These statements speak only as of the date they were made, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. We operate in a changing environment. New risks emerge from time to time and it is not possible for us to predict all risks that may affect us. For more information regarding these risks and uncertainties, as well as certain additional risks that we face, please refer to the Risk Factors detailed in Item 3 of Part III of our Annual Report on Form 20-F for the year ended December 31, 2018, and subsequent reports and registration statements filed from time to time with the Securities and Exchange Commission.

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

U.S. dollars in thousands (except per share amounts)

Three months ended

Nine months ended

September 30

September 30

2019

2018

2019

2018

(unaudited)

(unaudited)

(unaudited)

(unaudited)

Revenue

82,643

73,237

238,959

216,396

Cost of revenue

49,316

45,438

144,371

134,710

Gross profit

33,327

27,799

94,588

81,686

Operating expenses:

Research and development, net

9,445

8,350

27,145

26,130

Selling, marketing, general and administrative

13,767

12,635

39,797

39,117

Total operating expenses

23,212

20,985

66,942

65,247

Operating income

10,115

6,814

27,646

16,439

Financial expense, net

261

974

1,749

3,128

Taxes and other expenses, net

2,349

629

6,350

3,143

Net income

7,505

5,211

19,547

10,168

Attributable to non-controlling interest

87

28

134

135

Net income attributable to Sapiens' shareholders

7,418

5,183

19,413

10,033

Basic earnings per share

0.15

0.10

0.39

0.20

Diluted earnings per share

0.15

0.10

0.38

0.20

Weighted average number of shares outstanding used to compute basic earnings per share (in thousands)

50,027

49,826

50,005

49,795

Weighted average number of shares outstanding used to compute diluted earnings per share (in thousands)

50,742

50,143

50,534

50,070

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED NON-GAAP STATEMENTS OF INCOME

U.S. dollars in thousands (except per share amounts)

Three months ended

Nine months ended

September 30

September 30

2019

2018

2019

2018

(unaudited)

(unaudited)

(unaudited)

(unaudited)

Revenue

82,643

73,237

238,959

216,864

Cost of revenue

45,931

42,334

134,349

125,240

Gross profit

36,712

30,903

104,610

91,624

Operating expenses:

Research and development, net

10,986

9,658

31,648

29,908

Selling, marketing, general and administrative

12,196

10,972

35,101

33,005

Total operating expenses

23,182

20,630

66,749

62,913

Operating income

13,530

10,273

37,861

28,711

Financial expense, net

261

974

1,749

3,128

Taxes and other expenses

2,770

1,723

7,635

5,211

Net income

10,499

7,576

28,477

20,372

Attributable to non-controlling interest

87

28

134

135

Net income attributable to Sapiens' shareholders

10,412

7,548

28,343

20,237

Basic earnings per share

0.21

0.15

0.57

0.41

Diluted earnings per share

0.21

0.15

0.56

0.40

Weighted average number of shares outstanding used to compute basic earnings per share (in thousands)

50,027

49,826

50,005

49,795

Weighted average number of shares outstanding used to compute diluted earnings per share (in thousands)

50,742

50,143

50,534

50,070

SAPIENS INTERNATIONAL CORPORATION N.V. AND SUBSIDIARIES

RECONCILIATION OF GAAP TO NON-GAAP RESULTS

U.S. dollars in thousands (except per share amounts)

Three months ended

Nine months ended

September 30

September 30

2019

2018

2019

2018

(unaudited)

(unaudited)

(unaudited)

(unaudited)

GAAP revenue

82,643

73,237

238,959

216,396

Valuation adjustment on acquired deferred revenue

-

-

-

468

Non-GAAP revenue

82,643

73,237

238,959

216,864

GAAP gross profit

33,327

27,799

94,588

81,686

Valuation adjustment on acquired deferred revenue

-

-

-

468

Amortization of capitalized software

1,438

1,205

4,169

3,612

Amortization of other intangible assets

1,947

1,899

5,853

5,858

Non-GAAP gross profit

36,712

30,903

104,610

91,624

GAAP operating income

10,115

6,814

27,646

16,439

Gross profit adjustments

3,385

3,104

10,022

9,938

Capitalization of software development

(1,541)

(1,308)

(4,503)

(3,778)

Amortization of other intangible assets

539

739

1,614

2,367

Stock-based compensation

382

384

1,123

1,470

Acquisition-related costs *)

650

540

1,959

2,275

Non-GAAP operating income

13,530

10,273

37,861

28,711

GAAP net income attributable to Sapiens' shareholders

7,418

5,183

19,413

10,033

Operating income adjustments

3,415

3,459

10,215

12,272

Tax and other

(421)

(1,094)

(1,285)

(2,068)

Non-GAAP net income attributable to Sapiens' shareholders

10,412

7,548

28,343

20,237

(*) Acquisition-related costs pertain to charges on behalf of M&A agreements related to future performance targets and retention criteria, as well as third-party services, such as, tax, accounting and legal rendered until the acquisition date.

Summary of NON-GAAP Financial Information

U.S. dollars in thousands (except per share amounts)

Q3 2019

Q2 2019

Q1 2019

Q4 2018

Q3 2018

Revenues

82,643

79,529

76,787

73,433

73,237

Gross profit

36,712

34,794

33,104

31,320

30,903

Operating income

13,530

12,581

11,750

10,849

10,273

Net income to Sapiens' shareholders

10,412

9,541

8,390

7,826

7,548

Adjusted EBITDA

14,523

13,358

12,524

11,797

11,236

Basic earnings per share

0.21

0.19

0.17

0.16

0.15

Diluted earnings per share

0.21

0.19

0.17

0.16

0.15

Non-GAAP Revenues by Geographic Breakdown

U.S. dollars in thousands

Q3 2019

Q2 2019

Q1 2019

Q4 2018

Q3 2018

North America

44,413

39,216

38,149

34,974

36,734

Europe

30,273

33,881

32,193

30,850

30,611

Asia Pacific

4,087

3,515

3,670

3,140

3,480

South Africa

3,870

2,917

2,775

4,469

2,412

Total

82,643

79,529

76,787

73,433

73,237

Adjusted Free Cash-Flow

U.S. dollars in thousands

Q3 2019

Q2 2019

Q1 2019

Q4 2018

Q3 2018

Cash-flow from operating activities

18,671

15,507

10,550

11,509

6,370

Increase in capitalized software development costs

(1,541)

(1,570)

(1,392)

(1,382)

(1,308)

Capital expenditures

(973)

(1,079)

(641)

(204)

(831)

Capital expenditures related to new campus in India

(6,325)

-

-

-

-

Free cash-flow

9,832

12,858

8,517

9,923

4,231

Capital expenditures related to new campus in India

6,325

-

-

-

-

Cash payments attributed to acquisition-related costs(*) (**)

100

1,692

1,608

790

-

Adjusted free cash-flow

16,257

14,550

10,125

10,713

4,231

(*) Included in cash-flow from operating activities

(**) Acquisition-related payments pertain to payments on behalf of M&A agreements related to future performance targets and retention criteria, as well as third-party services, such as, tax, accounting and legal rendered until the acquisition date.

Adjusted EBITDA Calculation

U.S. dollars in thousands

Three months ended

Nine months ended

September 30

September 30

2019

2018

2019

2018

GAAP operating profit

10,115

6,814

27,646

16,439

Non-GAAP adjustments:

Amortization of capitalized software

1,438

1,205

4,169

3,612

Amortization of other intangible assets

2,486

2,638

7,467

8,225

Capitalization of software development

(1,541)

(1,308)

(4,503)

(3,778)

Stock-based compensation

382

384

1,123

1,470

Acquisition-related costs

650

540

1,959

2,275

Valuation adjustment on acquired deferred revenue

-

-

-

468

Non-GAAP operating profit

13,530

10,273

37,861

28,711

Depreciation

993

963

2,544

2,855

Adjusted EBITDA

14,523

11,236

40,405

31,566

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

U.S. dollars in thousands

September 30,

December 31,

2019

2018

(unaudited)

(unaudited)

ASSETS

CURRENT ASSETS

Cash and cash equivalents

73,138

64,628

Trade receivables, net and unbilled receivables

57,237

59,159

Other receivables and prepaid expenses

7,567

6,224

Total current assets

137,942

130,011

LONG-TERM ASSETS

Property and equipment, net

15,446

8,515

Severance pay fund

5,052

4,699

Goodwill and intangible assets, net

230,935

231,348

Operating lease right-of-use assets

52,747

-

Other long-term assets

5,445

4,292

Total long-term assets

309,625

248,854

TOTAL ASSETS

447,567

378,865

LIABILITIES AND EQUITY

CURRENT LIABILITIES

Trade payables

5,506

6,149

Current maturities of Series B Debentures

9,898

9,898

Accrued expenses and other liabilities

54,848

46,999

Current maturities of operating lease liabilities

8,155

-

Deferred revenue

22,691

18,057

Total current liabilities

101,098

81,103

LONG-TERM LIABILITIES

Series B Debentures, net of current maturities

58,803

68,577

Deferred tax liabilities

9,040

11,681

Other long-term liabilities

8,228

9,398

Long-term operating lease liabilities

47,663

-

Accrued severance pay

6,082

5,622

Total long-term liabilities

129,816

95,278

EQUITY

216,653

202,484

TOTAL LIABILITIES AND EQUITY

447,567

378,865

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONSOLIDATED STATEMENT OF CASH FLOW

U.S. dollars in thousands

For the nine months ended

September 30,

2019

2018

(unaudited)

(unaudited)

Cash flows from operating activities:

Net income

19,547

10,168

Reconciliation of net income (loss) to net cash provided by operating activities:

Depreciation and amortization

14,180

14,694

Accretion of discount on Series B Debentures

124

140

Capital gain from sale of property and equipment

(129)

-

Stock-based compensation related to options issued to employees

1,123

1,462

Net changes in operating assets and liabilities, net of amount acquired:

Trade receivables, net and unbilled receivables

3,642

(10,654)

Deferred tax assets

(2,664)

(2,448)

Other operating assets

1,425

(1,233)

Trade payables

(1,534)

1,657

Other operating liabilities

4,562

416

Deferred revenues

4,419

1,937

Severance pay

33

52

Net cash provided by operating activities

44,728

16,191

Cash flows from investing activities:

Purchase of property and equipment

(9,018)

(1,710)

Investment in deposit

(1,119)

-

Payments for business acquisition, net of cash acquired

(1,572)

(18,203)

Proceeds from sale of property and equipment

821

-

Capitalized software development costs

(4,503)

(3,778)

Net cash used in investing activities

(15,391)

(23,691)

Cash flows from financing activities:

Proceeds from employee stock options exercised

435

532

Distribution of dividend

(10,362)

-

Repayment of Series B Debentures

(9,898)

-

Repayment of loan

(4)

(41)

Payment of contingent considerations

(120)

(61)

Dividend to non-controlling interest

(66)

(47)

Net cash provided by financing activities

(20,015)

383

Effect of exchange rate changes on cash and cash equivalents

(812)

(271)

Increase (decrease) in cash and cash equivalents

8,510

(7,388)

Cash and cash equivalents at the beginning of period

64,628

71,467

Cash and cash equivalents at the end of period

73,138

64,079

Debentures Covenants

As of September 30, 2019, Sapiens was in compliance with all of its financial covenants under the indenture for the Series B Debentures that it issued in September 2017, based on having achieved the following in its consolidated financial results:

Covenant 1

  • Target shareholders' equity (excluding minority interest): above $120 million.
  • Actual shareholders' equity equal to $215 million.

Covenant 2

  • Target ratio of net financial indebtedness to net capitalization (in each case, as defined under the indenture for the Company's Series B Debentures) bellow 65%.
  • Actual ratio of net financial indebtedness to net capitalization equal to -1.81%.

Covenant 3

  • Target ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is below 5.5.
  • Actual ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is equal to -0.07.

Investors and Media Contact Yaffa Cohen-Ifrah

Chief Marketing Officer and Head of Corporate CommunicationsSapiens InternationalU.S. Mobile: +1 201-250-9414Mobile: +972 54-9099039Email: [email protected]

Cision View original content:http://www.prnewswire.com/news-releases/sapiens-reports-third-quarter-2019-financial-results-300950592.html

SOURCE Sapiens International Corporation

Categories

PRNewswire Press Releases

Next Articles